Oscar Krijgsman

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi et al. · Nature Communications · 2014 · 621 citations · Full text

Tumor Biology, Oncology, Medicine +10

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat et al. · Proceedings of the National Academy of Sciences · 2015 · 477 citations · Full text

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Elisa A. Rozeman, Esmée P. Hoefsmit, Irene L. M. Reijers et al. · Nature Medicine · 2021 · 322 citations

Biomarker Analyses, Medicine, Melanoma +8

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman et al. · Nature Communications · 2021 · 317 citations · Full text

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

Kathrin Renner, Annette Schnell, Gudrun E. Koehl et al. · Cell Reports · 2019 · 286 citations · Full text